Back

Overexpression of HIF-2α in Alzheimer's disease Resilient Patients

Mitri, V.

2020-09-01 neurology
10.1101/2020.08.27.20180331
Show abstract

Alzheimers disease (AD) Resilient individuals are characterized by having a degree of amyloid plaques at level with that of demented individuals, but a reduced amount of abnormal neurofibrillary protein "tangles" (NFTs). NFTs, also known to be upregulated under hypoxic conditions, become clinically relevant when involved in the stratum radiatum. In this paper, we show this region and more to have significant increases of hypoxic adaptive protein, HIF-2, within AD resilient cases. Pericyte staining was present in the stratum lacunosum and radiatum of all cases affected by AD pathology (n = 4) but in AD resilient cases were increased by 12-fold (n=3) p<.0001. No staining was detected in normal cases (n=2). HIF-2 was also only present in hippocampal neuronal nuclei of AD resilient cases, including the dentate gyrus and CA1. Cytoplasmic staining of pyramidal neurons within the subiculum was seen in all cases affected by AD pathology. The intensity of HIF-2 appears to be specific to known regions of protection in AD resilience and to increase on a gradient that corresponds to protection against dementia. These results also highlight the stratum lacunosum and radiatum as regions critically impacted by hypoxic insult among AD cases. SignificanceHIF-2 directly regulates expression of erythropoietin (EPO), a neuroprotective glycoprotein that in brain pericytes is completely dependent upon activation of HIF-2. To date, only indirect evidence exists that shows that brain pericyte-derived EPO can reach the bloodstream via HIF-2 expression (Urrutia et al, 2016). In this study, we provide novel preliminary findings that directly show HIF-2 expression in pericytes of human brains. Additionally, its localization is specific to the CA1 of the hippocampus, a region critical for hypoxic adaptation and the progression of Alzheimers disease. Finally, we present evidence of neuronal expression of HIF-2 in other critical regions of protection within AD resilient cases.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Alzheimer's Research & Therapy
based on 31 papers
Top 0.1%
18.2%
2
Alzheimer's & Dementia
based on 84 papers
Top 1%
16.4%
3
Journal of Alzheimer's Disease
based on 31 papers
Top 0.3%
11.9%
4
Journal of Alzheimer’s Disease
based on 23 papers
Top 0.7%
5.0%
50% of probability mass above
5
Brain Communications
based on 79 papers
Top 2%
4.8%
6
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
based on 28 papers
Top 1%
3.0%
7
Neurobiology of Aging
based on 29 papers
Top 0.9%
3.0%
8
Frontiers in Aging Neuroscience
based on 22 papers
Top 1%
2.0%
9
Alzheimer's & Dementia: Translational Research & Clinical Interventions
based on 13 papers
Top 0.7%
2.0%
10
Molecular Psychiatry
based on 84 papers
Top 4%
2.0%
11
Frontiers in Neurology
based on 74 papers
Top 7%
1.9%
12
PLOS ONE
based on 1737 papers
Top 88%
1.7%
13
European Journal of Neurology
based on 20 papers
Top 2%
1.4%
14
Brain
based on 69 papers
Top 5%
1.4%
15
Neurology
based on 38 papers
Top 5%
1.4%
16
Neurobiology of Disease
based on 12 papers
Top 0.7%
1.4%
17
Translational Psychiatry
based on 94 papers
Top 7%
1.3%
18
NeuroImage: Clinical
based on 77 papers
Top 6%
1.3%
19
The Journals of Gerontology: Series A
based on 19 papers
Top 2%
0.9%
20
Biomedicines
based on 21 papers
Top 3%
0.9%
21
Annals of Neurology
based on 43 papers
Top 5%
0.9%
22
Acta Neuropathologica Communications
based on 10 papers
Top 0.6%
0.9%
23
Acta Neuropathologica
based on 11 papers
Top 1%
0.9%
24
Journal of Neurology, Neurosurgery & Psychiatry
based on 26 papers
Top 5%
0.7%
25
Frontiers in Neuroscience
based on 29 papers
Top 4%
0.7%